$13.73
00.00%
Pre-Market: Sep 20, 4:02 PM EDT
15 minutes delayed
Y-mAbs Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Y-mAbs Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-12 | $-0.21 | $-0.13 | -61.5 % |
Mar 2024 | 2024-05-07 | $-0.15 | $-0.14 | -7.14 % |
Dec 2023 | 2024-02-29 | $-0.02 | $-0.20 | 90.0 % |
Sep 2023 | 2023-11-13 | $-0.18 | $-0.19 | 5.26 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-12 | $22.80M | $23.02M | -0.96 % |
Mar 2024 | 2024-05-07 | $19.93M | $22.22M | -10.3 % |
Dec 2023 | 2024-02-29 | $23.36M | $20.95M | 11.5 % |
Sep 2023 | 2023-11-13 | $20.45M | $20.93M | -2.27 % |
Y-mAbs Therapeutics (YMAB) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 12, 2024 for Q2.
The Actual EPS was $-0.21, which missed the estimate of $-0.13.
The Actual Revenue was $22.8M, which missed the estimate of $23M.
Browse earnings estimates, EPS, and revenue on all stocks.